Exhibit 2
Year ended December 31, | ||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | Total | |||||||||||||||||||
Net Income (loss) - as previously reported | $ | (1,654 | ) | $ | 6,279 | $ | (41,785 | ) | $ | (5,500 | ) | $ | 914 | $ | 24,150 | $ | 52,640 | |||||||||
Restatement effect: | ||||||||||||||||||||||||||
Costs of goods sold | 61 | 156 | 143 | 138 | 261 | 209 | 191 | |||||||||||||||||||
Research and development, net | 192 | 527 | 531 | 447 | 1,146 | 1,061 | 961 | |||||||||||||||||||
Selling and marketing | 444 | 1,224 | 1,145 | 933 | 1,729 | 1,625 | 2,441 | |||||||||||||||||||
General and administrative | 139 | 410 | 330 | 183 | 725 | 726 | 673 | |||||||||||||||||||
Total restatement effect | 836 | 2,317 | 2,149 | 1,701 | 3,861 | 3,621 | 4,266 | 18,751 | ||||||||||||||||||
Net Income (loss) - as restated | $ | (2,490 | ) | $ | 3,962 | $ | (43,934 | ) | $ | (7,201 | ) | $ | (2,947 | ) | $ | 20,529 | $ | 48,374 | ||||||||
Year ended December 31, 2003 | Year ended December 31, 2004 | Year ended December 31, 2005 | |||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
As previously reported | Adjustments | As restated | As previously reported | Adjustments | As restated | As previously reported | Adjustments | As restated | |||||||||||||||||||||
Revenues | $ | 130,054 | $ | 0 | $ | 130,054 | $ | 416,560 | $ | 0 | $ | 416,560 | $ | 614,983 | $ | 0 | $ | 614,983 | |||||||||||
Costs and expenses: | |||||||||||||||||||||||||||||
Costs of goods sold | 93,114 | 261 | 93,375 | 303,320 | 209 | 303,529 | 462,236 | 191 | 462,427 | ||||||||||||||||||||
Research and development, net | 14,714 | 1,146 | 15,860 | 24,834 | 1,061 | 25,895 | 37,456 | 961 | 38,417 | ||||||||||||||||||||
Selling and marketing | 19,419 | 1,729 | 21,148 | 31,077 | 1,625 | 32,702 | 33,523 | 2,441 | 35,964 | ||||||||||||||||||||
General and administrative | 4,852 | 725 | 5,577 | 6,904 | 726 | 7,630 | 12,143 | 673 | 12,816 | ||||||||||||||||||||
In-process research and development write off | 0 | 0 | 0 | 0 | 0 | 0 | 2,460 | 0 | 2,460 | ||||||||||||||||||||
Total costs and expenses | 132,099 | 3,861 | 135,960 | 366,135 | 3,621 | 369,756 | 547,818 | 4,266 | 552,084 | ||||||||||||||||||||
Operating income (loss) | (2,045 | ) | (3,861 | ) | (5,906 | ) | 50,425 | (3,621 | ) | 46,804 | 67,165 | (4,266 | ) | 62,899 | |||||||||||||||
Financial income, net | 2,711 | 0 | 2,711 | 3,920 | 0 | 3,920 | 8,688 | 0 | 8,688 | ||||||||||||||||||||
Other income, net | 131 | 0 | 131 | 183 | 0 | 183 | 6,325 | 0 | 6,325 | ||||||||||||||||||||
Income (loss) before taxes on income | 797 | (3,861 | ) | (3,064 | ) | 54,528 | (3,621 | ) | 50,907 | 82,178 | (4,266 | ) | 77,912 | ||||||||||||||||
Taxes on income | 0 | 0 | 0 | 0 | 0 | 0 | 156 | 0 | 156 | ||||||||||||||||||||
Income (loss) after taxes on income | 797 | (3,861 | ) | (3,064 | ) | 54,528 | (3,621 | ) | 50,907 | 82,022 | (4,266 | ) | 77,756 | ||||||||||||||||
Equity in losses of an affiliate | 0 | 0 | 0 | 0 | 0 | 0 | 3,146 | 0 | 3,146 | ||||||||||||||||||||
Minority interest in losses (earnings) of subsidiaries | (117 | ) | 0 | (117 | ) | 30,378 | 0 | 30,378 | 26,236 | 0 | 26,236 | ||||||||||||||||||
Net income (loss) | $ | 914 | $ | (3,861 | ) | $ | (2,947 | ) | $ | 24,150 | $ | (3,621 | ) | $ | 20,529 | $ | 52,640 | $ | (4,266 | ) | $ | 48,374 | |||||||
Basic net earnings (loss) per share | $ | 0.03 | $ | (0.13 | ) | $ | (0.10 | ) | $ | 0.71 | $ | (0.11 | ) | $ | 0.60 | $ | 1.46 | $ | (0.12 | ) | $ | 1.34 | |||||||
Diluted net earnings (loss) per share | $ | 0.03 | $ | (0.13 | ) | $ | (0.10 | ) | $ | 0.66 | $ | (0.10 | ) | $ | 0.56 | $ | 1.30 | $ | (0.10 | ) | $ | 1.20 | |||||||
Weighted average number of Ordinary Shares used in | |||||||||||||||||||||||||||||
computing basic net earnings (loss) per share | 28,178,228 | 0 | 28,178,228 | 34,195,642 | 0 | 34,195,642 | 36,164,979 | 0 | 36,164,979 | ||||||||||||||||||||
Weighted average number of Ordinary Shares used in | |||||||||||||||||||||||||||||
computing diluted net earnings (loss) per share | 30,513,485 | (2,335,257 | ) | 28,178,228 | 36,823,118 | (475,177 | ) | 36,347,941 | 41,156,678 | (317,983 | ) | 40,838,695 | |||||||||||||||||